12:00 AM
 | 
Jul 01, 2013
 |  BC Week In Review  |  Company News  |  Deals

Indicia Biotechnology, Platine Pharma Services S.A.S., Transgene deal

Platine will acquire Indicia's immune-monitoring activities, which includes the development of immunoassays as well as the Immunoline platform to assess the immunogenicity risk of biologics, in a stock deal. The deal will be...

Read the full 144 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >